AbbVie’s Rinvoq marches toward blockbuster ulcerative colitis nod even as JAK delays drag on

AbbVie has pegged much of its post-Humira hopes on its next-gen immunology med Rinvoq, which now appears one step closer toward what could be a $ 2 billion indication in ulcerative colitis.  The Chicago-based pharma said on Tuesday that its rheumatoid arthritis drug “significantly” topped placebo at helping moderate to severe ulcerative colitis patients reach clinical remission after… Read More »

Economists doubt India’s new loan guarantees will boost growth

Industry leaders and economists said the new loan guarantees, amounting to $ 35 billion, may provide some temporary relief but would not be sufficient to boost economic growth. Sitharaman said the government would waive visa fees for 500,000 foreign tourists and extend loan guarantees to health, tourism and small businesses amounting to 1.1 trillion rupees… Read More »